ArticleCurrent microbiology2025
Degradation of Resistant α-1,4-glucan by Vaginal Gardnerella Species is Associated with Bacterial Vaginosis.
Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the degradation of resistant α-1,4-glucan by vaginal bacterial species, with a focus on Gardnerella spp., to elucidate its role in bacterial vaginosis (BV). The ability of Gardnerella vaginalis, Gardnerella swidsinskii, Gardnerella leopoldii, Gardnerella piotii, Lactobacillus iners, and Lactobacillus crispatus was assessed to metabolize an ungelatinized, labeled form of raw amylose, a degradation-resistant α-1,4-glucan. The enzymatic activity of these species was evaluated in vitro, and its association with BV was examined in vaginal swabs. Gardnerella vaginalis, G. swidsinskii, and G. leopoldii demonstrated the best ability to degrade resistant α-1,4-glucan in vitro. Unlike the cell-bound, S-layer-associated glycogen-degrading activity in L. crispatus, this α-glucosidase activity in Gardnerella was also extracellular, but not cell-bound and not repressed by glucose. Vaginal swabs showing high rates of resistant α-1,4-glucan degradation activity were associated with BV, particularly in the concurrent presence of G. leopoldii, G. swidsinskii, and G. vaginalis. These findings suggest a role of α-1,4-glucan degradation in BV pathogenesis mediated by Gardnerella species. The results indicate the potential of targeting bacterial amylase activity as therapeutic strategy for BV prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.